| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,115 | 9,348 | 9,172 | 9,658 | | Cost of Revenue | 8,184 | 7,067 | 6,646 | 7,184 | | | Gross Profit | 2,931 | 2,281 | 2,526 | 2,474 | | | Operating Expenses | | Research Development | 1,810 | 2,117 | 2,465 | 2,667 | | Selling General and Administrative | 3,826 | 3,617 | 3,447 | 3,508 | | Non Recurring | 717 |
-
|
-
| 5,258 | | Others | 6 | 6 | 6 | 72 | | | | Total Operating Expenses | 6,359 |
-
|
-
| 11,505 | | | | Operating Income or Loss | (3,428) | (3,459) | (3,392) | (9,031) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5) | (11) | 30 | 130 | | Earnings Before Interest And Taxes | (3,433) | (3,470) | (3,362) | (8,901) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,433) | (3,470) | (3,362) | (8,901) | | Income Tax Expense | 41 | (18) | 6 | 10 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,474) | (3,452) | (3,368) | (8,911) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,474) | (3,452) | (3,368) | (8,911) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,474) | ($3,452) | ($3,368) | ($8,911) |
|
0.51% Nasdaq 
Income Statement
